Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosis

Fertility and Sterility
J DonnezF Casanas-Roux

Abstract

One hundred infertile patients with laparoscopically confirmed ovarian endometriosis were treated with either intranasal (IN) Buserelin (Hoechst, AG, Frankfurt am Main, West Germany) (300 micrograms three times a day) or subcutaneous (SC) Buserelin implant (6.6 mg Buserelin). Serum estradiol was suppressed in the menopausal range in both groups, but the inhibition of the pituitary ovarian axis appeared more profound and consistent in the SC group than in the IN group. Laparoscopic findings proved that the SC Buserelin emerged superior to the IN Buserelin. Indeed, the score of endometriotic lesions and the ovarian cyst diameter were more reduced in the SC group than in the IN group. Moreover, the histologic study showed a lower incidence of active endometriosis and a lower mitotic index of ovarian endometrial epithelium in the SC group than in the IN group. In conclusion, the release of a gonadotropin-releasing hormone agonist by a biodegradable implant achieved better efficacy in reducing endometriotic lesions than the IN mode of administration.

Citations

Aug 28, 1998·Current Opinion in Obstetrics & Gynecology·C Farquhar, C Sutton
Jul 20, 2007·The Cochrane Database of Systematic Reviews·A PrenticeS K Smith
Feb 1, 1992·British Journal of Obstetrics and Gynaecology·J DonnezF Clerckx
Dec 1, 1990·DICP : the Annals of Pharmacotherapy·N A LetassyR R Suda
Apr 1, 1996·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·T SusiniG B Massi
Mar 30, 1999·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J Donnez
Aug 23, 2000·Current Opinion in Obstetrics & Gynecology·K D Jones, C J Sutton
Dec 3, 2003·Annals of the New York Academy of Sciences·Jacques DonnezJean Squifflet
Dec 1, 1992·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·V Aleandri, G Benagiano
Nov 30, 2014·Human Reproduction·U Leone Roberti MaggioreS Ferrero
Dec 15, 2010·The Cochrane Database of Systematic Reviews·Julie BrownRoger J Hart
Jun 6, 2000·Advanced Drug Delivery Reviews·V D RomeoC R Behl
Apr 18, 2003·Obstetrics and Gynecology Clinics of North America·Paolo VercelliniPier Giorgio Crosignani
Jul 3, 2017·Fertility and Sterility·Christian M BeckerSukhbir S Singh
Dec 16, 2011·Animal Reproduction Science·A Dal BoscoC Castellini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.